Cargando…

Thrombotic complications in 2928 patients with COVID-19 treated in intensive care: a systematic review

A prothrombotic state is reported with severe COVID-19 infection, which can manifest in venous and arterial thrombotic events. Coagulopathy is reflective of more severe disease and anticoagulant thromboprophylaxis is recommended in hospitalized patients. However, the prevalence of thrombosis on the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jenner, William J., Kanji, Rahim, Mirsadraee, Saeed, Gue, Ying X., Price, Susanna, Prasad, Sanjay, Gorog, Diana A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882250/ https://www.ncbi.nlm.nih.gov/pubmed/33586113 http://dx.doi.org/10.1007/s11239-021-02394-7

Ejemplares similares

Incidence of thrombotic complications in COVID-19: On behalf of ICODE: The International COVID-19 Thrombosis Biomarkers Colloquium
por: Jenner, William J., et al.
Publicado: (2021)

Rationale and design of “Can Very Low Dose Rivaroxaban (VLDR) in addition to dual antiplatelet therapy improve thrombotic status in acute coronary syndrome (VaLiDate-R)” study: A randomised trial modulating endogenous fibrinolysis in patients with acute coronary syndrome
por: Gue, Ying X., et al.
Publicado: (2019)

MI with Non-obstructive Coronary Artery Presenting with STEMI: A Review of Incidence, Aetiology, Assessment and Treatment
por: Gue, Ying X, et al.
Publicado: (2020)

Fibrinolysis in Platelet Thrombi
por: Kanji, Rahim, et al.
Publicado: (2021)

Incidence of Thrombotic Complications in COVID-19: On Behalf of ICODE: The International COVID-19 Thrombosis Biomarkers Colloquium
por: Jenner, W.J., et al.
Publicado: (2021)

Angiotensin Converting Enzyme 2 May Mediate Disease Severity In COVID-19
por: Gue, Ying Xuan, et al.
Publicado: (2020)

Author Correction: Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19
por: Gue, Ying X., et al.
Publicado: (2021)

Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19
por: Gue, Ying X., et al.
Publicado: (2020)

A case of repetitive myocardial infarction with unobstructed coronaries due to Churg–Strauss syndrome
por: Gue, Ying X, et al.
Publicado: (2019)

Determinants of Endogenous Fibrinolysis in Whole Blood Under High Shear in Patients With Myocardial Infarction
por: Kanji, Rahim, et al.
Publicado: (2022)

Virulence-related Mycobacterium avium subsp hominissuis MAV_2928 gene is associated with vacuole remodeling in macrophages
por: Jha, Samradhni S, et al.
Publicado: (2010)

Importance of Endogenous Fibrinolysis in Platelet Thrombus Formation
por: Gue, Ying X., et al.
Publicado: (2017)

A rare cause of myocardial infarction with non-obstructive coronary arteries—case report of ST-segment elevation myocardial infarction caused by a mediastinal mass
por: Gue, Ying X, et al.
Publicado: (2018)

Measuring Thrombus Stability at High Shear, Together With Thrombus Formation and Endogenous Fibrinolysis: First Experience Using the Global Thrombosis Test 3 (GTT-3)
por: Kanji, Rahim, et al.
Publicado: (2023)

Fatal heart block from intentional yew tree (Taxus baccata) ingestion: a case report
por: G., Natasha, et al.
Publicado: (2019)

Adjunctive therapies to reduce thrombotic events in patients with a history of myocardial infarction: role of vorapaxar
por: Farag, Mohamed, et al.
Publicado: (2015)

Delayed Thrombotic Complications in a Thrombotic Thrombocytopenic Purpura Patient Treated With Caplacizumab
por: Cilla, Nicolas, et al.
Publicado: (2020)

Precision Treatment in ACS–Role of Assessing Fibrinolysis
por: Gue, Ying X., et al.
Publicado: (2021)

Treating Thrombotic Complications in Patients with Primary Intracerebral Haemorrhage
por: Cohen, D L
Publicado: (1998)

Thrombotic Complications in Immune Thrombocytopenia Patients Treated with Avatrombopag
por: Abdelsamia, Mahmoud, et al.
Publicado: (2023)

Catheter ablation for AF improves global thrombotic profile and enhances fibrinolysis
por: Niespialowska-Steuden, Maria, et al.
Publicado: (2017)

A thrombotic complication of COVID-19: cerebral ischaemia in the intensive care unit
por: Şahin, Ayça Sultan, et al.
Publicado: (2020)

Peripartum cardiomyopathy and thrombotic complications
por: Aksu, Ugur, et al.
Publicado: (2019)

Thrombotic complications of COVID-19
por: Avila, Jacob, et al.
Publicado: (2021)

Placenta percreta complicated by uterine rupture and thrombotic microangiopathy
por: Laužikienė, Dalia, et al.
Publicado: (2018)

D122. The Impact of Tamoxifen Therapy on Thrombotic Flap Complications: A Nationwide Analysis
por: Yesantharao, Pooja S., et al.
Publicado: (2023)

Impaired endogenous fibrinolysis at high shear using a point-of-care test in STEMI is associated with alterations in clot architecture
por: Spinthakis, Nikolaos, et al.
Publicado: (2019)

Thrombotic Complications in COVID-19 Patients: Low Incidence of Thrombotic Complications Among Critically Ill COVID-19 Patients in Singapore
por: Lim, Cheryl XQ, et al.
Publicado: (2020)

Thrombotic complication during intracoronary imaging
por: Wiyono, S. A., et al.
Publicado: (2012)

Complicated case of COVID-19 disease with overlapping features of thrombotic thrombocytopenic purpura and haemophagocytic lymphohistiocytosis
por: Verma, Durga Prasad, et al.
Publicado: (2021)

Thrombotic complications of patients admitted to intensive care with COVID-19 at a teaching hospital in the United Kingdom
por: Thomas, W., et al.
Publicado: (2020)

Thrombotic microangiopathy as a complication of recurrent pancreatitis
por: Malleshappa, P., et al.
Publicado: (2011)

Disseminated cerebral aspergillosis complicated by thrombotic microangiopathy
por: Lester, Robynn, et al.
Publicado: (2019)

Management of Thrombotic Complications in COVID-19: An Update
por: Hajra, Adrija, et al.
Publicado: (2020)

COVID-19 Associated Coagulopathy and Thrombotic Complications
por: Mezalek, Zoubida Tazi, et al.
Publicado: (2020)

Arterial thrombotic complications in COVID-19 patients
por: Levolger, Stef, et al.
Publicado: (2020)

Thrombotic and Hypercoagulability Complications of COVID-19: An Update
por: Shibeeb, Sapha, et al.
Publicado: (2021)

Thrombotic Complications Associated with Immune Checkpoint Inhibitors
por: Wang, Tzu-Fei, et al.
Publicado: (2021)

Thrombotic Complications in Patients with Immune-Mediated Hemolysis
por: Capecchi, Marco, et al.
Publicado: (2021)

Thrombotic Complications in Patients with COVID-19: Pathophysiological Mechanisms, Diagnosis, and Treatment
por: Gąsecka, Aleksandra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d0q2o1ohk0c37scec7j9bbqt72